Exicure (XCUR) EBT Growth (3y) (2019 - 2026)
Exicure (XCUR) EBT Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
28.95% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-49.71% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
20.92% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
12.01% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Exicure |
19.38 Mn |
16.77 Mn |
- |
25.42% |
| Date | Value |
|---|
| Mar 31, 2026 |
25.42% |
| Dec 31, 2025 |
-29.86% |
| Sep 30, 2025 |
22.12% |
| Jun 30, 2025 |
29.47% |
| Mar 31, 2025 |
33.15% |
| Dec 31, 2024 |
19.62% |
| Sep 30, 2024 |
64.16% |
| Jun 30, 2024 |
65.23% |
| Mar 31, 2024 |
59.50% |
| Dec 31, 2023 |
51.06% |
| Sep 30, 2023 |
15.85% |
| Jun 30, 2023 |
-10.17% |
| Mar 31, 2023 |
-80.00% |
| Dec 31, 2022 |
57.47% |
| Sep 30, 2022 |
5.67% |
| Jun 30, 2022 |
-12.94% |
| Mar 31, 2022 |
-13.17% |
| Dec 31, 2021 |
-39.96% |
| Sep 30, 2021 |
-57.41% |
| Jun 30, 2021 |
-33.70% |
